XBiotech Inc. - Common Shares, no par value (XBIT)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Shares, no par value
Shares outstanding
33,289,095
Number of holders
51
Total 13F shares, excl. options
3,965,072
Shares change
-140,976
Total reported value, excl. options
$44,131,901
Value change
-$1,897,441
Put/Call ratio
2.97%
Number of buys
22
Number of sells
-25
Price
$11.13

Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q4 2021

69 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q4 2021.
XBiotech Inc. - Common Shares, no par value (XBIT) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3,965,072 shares of 33,289,095 outstanding shares and own 11.91% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,055,776 shares), VANGUARD GROUP INC (940,807 shares), STATE STREET CORP (438,857 shares), GEODE CAPITAL MANAGEMENT, LLC (309,381 shares), NORTHERN TRUST CORP (211,012 shares), DIMENSIONAL FUND ADVISORS LP (102,046 shares), Nuveen Asset Management, LLC (85,962 shares), AQR CAPITAL MANAGEMENT LLC (68,647 shares), Bank of New York Mellon Corp (59,734 shares), and Allspring Global Investments Holdings, LLC (59,141 shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.